Investors

Insider Transactions

Date Name Sorted Ascending Title Type Shares Traded Price Range
Feb 25, 2014 goldstein joseph l Director Sell 1,000 338.86
Feb 20, 2014 goldstein joseph l Director Sell 1,000 326.96 - 327.17
Feb 12, 2014 goldstein joseph l Director Sell 1,000 320.62
Nov 6, 2013 goldstein joseph l Director Sell 1,000 300.74
Aug 23, 2013 goldstein joseph l Director Sell 1,000 238.29
Aug 14, 2013 goldstein joseph l Director Acquisition (Non Open Market) 5,000 n/a
May 28, 2013 goldstein joseph l Director Sell 4,000 252.20
May 20, 2013 goldstein joseph l Director Acquisition (Non Open Market) 4,000 n/a
Apr 1, 2013 goldstein joseph l Director Option Execute 5,000 24.41
Apr 1, 2013 goldstein joseph l Director Automatic Sell 5,000 180.00
Jan 9, 2013 goldstein joseph l Director Option Execute 5,000 57.11
Jan 9, 2013 goldstein joseph l Director Automatic Sell 5,000 185.00
Jan 4, 2013 goldstein joseph l Director Option Execute 5,000 33.42
Jan 4, 2013 goldstein joseph l Director Automatic Sell 5,000 180.50 - 181.22
Mar 26, 2012 goldstein joseph l Director Option Execute 5,000 18.61
Mar 26, 2012 goldstein joseph l Director Automatic Sell 5,000 120.00
Mar 15, 2012 goldstein joseph l Director Option Execute 10,000 18.61
Mar 15, 2012 goldstein joseph l Director Automatic Sell 10,000 110.77 - 115.00
Feb 14, 2012 goldstein joseph l Director Option Execute 15,000 24.41 - 33.42
Feb 14, 2012 goldstein joseph l Director Automatic Sell 15,000 110.02
Showing 301-320 of 1021 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)